Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54.5M
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
31.7M
-
Shares change
-
+3.33M
-
Total reported value, excl. options
-
$265M
-
Value change
-
+$31M
-
Put/Call ratio
-
2.1
-
Number of buys
-
61
-
Number of sells
-
-79
-
Price
-
$8.35
Significant Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q3 2024
180 filings reported holding EBS - Emergent BioSolutions Inc. - Common Stock as of Q3 2024.
Emergent BioSolutions Inc. - Common Stock (EBS) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.7M shares
of 54.5M outstanding shares and own 58.15% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.4M shares), MARSHALL WACE, LLP (2.49M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (2.22M shares), BlackRock, Inc. (1.99M shares), STATE STREET CORP (1.91M shares), AMERICAN CENTURY COMPANIES INC (1.73M shares), MORGAN STANLEY (1.22M shares), OAK HILL ADVISORS LP (1.11M shares), Invesco Ltd. (901K shares), and Connor, Clark & Lunn Investment Management Ltd. (833K shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.